Courtney Breen
Stock Analyst at Bernstein
(0.39)
# 4,277
Out of 5,152 analysts
4
Total ratings
n/a
Success rate
-2.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Downgrades: Market Perform | $335 | $379.27 | -11.67% | 1 | Jan 20, 2026 | |
| LLY Eli Lilly and Company | Maintains: Outperform | $1,100 → $1,300 | $1,003.57 | +29.54% | 1 | Nov 24, 2025 | |
| MRNA Moderna | Initiates: Market Perform | $55 | $57.80 | -4.84% | 1 | Oct 17, 2024 | |
| PFE Pfizer | Initiates: Market Perform | $32 | $26.62 | +20.21% | 1 | Oct 17, 2024 |
Amgen
Jan 20, 2026
Downgrades: Market Perform
Price Target: $335
Current: $379.27
Upside: -11.67%
Eli Lilly and Company
Nov 24, 2025
Maintains: Outperform
Price Target: $1,100 → $1,300
Current: $1,003.57
Upside: +29.54%
Moderna
Oct 17, 2024
Initiates: Market Perform
Price Target: $55
Current: $57.80
Upside: -4.84%
Pfizer
Oct 17, 2024
Initiates: Market Perform
Price Target: $32
Current: $26.62
Upside: +20.21%